NYSEMKT: CANF
Can Fite Biopharma Ltd Stock Forecast, Predictions & Price Target

Analyst price target for CANF

Based on 2 analysts offering 12 month price targets for Can Fite Biopharma Ltd

Min Forecast
$50.00+1,606.48%
Avg Forecast
$65.00+2,118.43%
Max Forecast
$80.00+2,630.38%

Should I buy or sell CANF stock?

Based on 2 analysts offering ratings for Can Fite Biopharma Ltd.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CANF stock forecasts and price targets.

CANF stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-17
lockedlocked$00.00+00.00%2025-11-04

1 of 1

CANF vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CANF$2.93$65.00+2,118.43%Strong Buy
XRTX$2.78N/AN/A
GLMD$0.57N/AN/A
VIVS$1.44N/AN/A
AZTR$0.25N/AN/A

Can Fite Biopharma Stock Forecast FAQ

Is Can Fite Biopharma Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSEMKT: CANF) stock is to Strong Buy CANF stock.

Out of 2 analysts, 1 (50%) are recommending CANF as a Strong Buy, 1 (50%) are recommending CANF as a Buy, 0 (0%) are recommending CANF as a Hold, 0 (0%) are recommending CANF as a Sell, and 0 (0%) are recommending CANF as a Strong Sell.

If you're new to stock investing, here's how to buy Can Fite Biopharma stock.

What is CANF's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CANF price target, the average CANF price target is $65.00, with the highest CANF stock price forecast at $80.00 and the lowest CANF stock price forecast at $50.00.

On average, Wall Street analysts predict that Can Fite Biopharma's share price could reach $65.00 by Dec 17, 2026. The average Can Fite Biopharma stock price prediction forecasts a potential upside of 2,118.43% from the current CANF share price of $2.93.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.